A pharmaceutical activity license in Russia has no expiry date. What is checked at pharmacies and wholesalers in 2026
A pharmaceutical activity license has no expiry date under Federal Law No. 99-FZ of 4 May 2011 «On the Licensing of Certain Types of Activity» (hereinafter 99-FZ). 99-FZ provides for periodic confirmation of compliance (an assessment of the licensee at its request, as a general rule every three years) only for the types of activity that it lists separately. The manufacture of medicines is on that list, so manufacturers undergo the confirmation. Pharmaceutical activity is not on the list.
The procedure for licensing pharmaceutical activities is established by the Licensing Regulation approved by Resolution of the Government of the Russian Federation No. 547 of 31 March 2022 (hereinafter Resolution No. 547). Resolution No. 547 is in force until 1 September 2028. The latest amendments were made by Resolution of the Government of the Russian Federation No. 324 of 27 March 2026 (hereinafter Resolution No. 324) and apply from 5 April 2026.
Which work the license covers and which authority issues it
The Licensing Regulation applies to legal entities, including foreign ones, and to individual entrepreneurs: wholesale organizations, pharmacy organizations, veterinary pharmacy organizations, veterinary organizations, and medical organizations and their separate subdivisions located in rural settlements without pharmacy organizations. Pharmaceutical activity includes the work and services listed in the Licensing Regulation. Nine items are listed for medicines for medical use and eight for veterinary use (Table 1).
Table 1. Work and services that make up pharmaceutical activity
| Work or service | Medical use | Veterinary use |
|---|---|---|
| Wholesale trade in medicines | Yes | Yes |
| Storage of medicines | Yes | Yes |
| Storage of medicinal products | Yes | Yes |
| Transport of medicines | Yes | Yes |
| Transport of medicinal products | Yes | Yes |
| Retail trade in medicinal products | Yes | Yes |
| Dispensing of medicinal products | Yes | Yes |
| Preparation of medicinal products (for medical use, except radiopharmaceutical medicinal products) | Yes | Yes |
| Preparation of radiopharmaceutical medicinal products | Yes | No |
Three authorities carry out licensing. The Federal Service for Surveillance in Healthcare (Roszdravnadzor) licenses wholesale organizations for medicines for medical use and pharmacy organizations subordinate to federal executive authorities. The executive authorities of the constituent entities of the Russian Federation license other organizations, individual entrepreneurs and foreign legal entities in the sphere of medicines for medical use. Activity in the sphere of medicines for veterinary use is licensed by the Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor).
From 1 September 2026 to 1 September 2029, a pilot project for the retail trade in medicinal products for medical use through mobile pharmacy units is in progress. The rules of the pilot project were added to Federal Law No. 61-FZ of 12 April 2010 «On the Circulation of Medicines» (hereinafter 61-FZ) by Federal Law No. 125-FZ of 2 May 2026. The trade is conducted by pharmacy organizations, other than individual entrepreneurs, that hold a permit for such trade from the federal body for control and supervision in the sphere of healthcare and a license for the retail trade, storage and transport of medicinal products for medical use that they have held for at least three years. The Russian Government approves the regulation on the procedure for the pilot project and the rules for issuing this permit.
What changed in Resolution No. 547 and in the rules to which it refers
The current version of Resolution No. 547 differs from the version of 6 November 2024 in the time limit for deciding on a license application and in the education requirement for a specialist working with veterinary medicines. Resolution No. 324 split the decision time limit by type of use. The education requirement changed twice: by Resolution of the Government of the Russian Federation No. 232 of 26 February 2025 (hereinafter Resolution No. 232) and by Resolution No. 324. Orders of the Russian Ministry of Health No. 259n of 29 April 2025 (hereinafter Rules No. 259n) and No. 260n of 29 April 2025 (hereinafter Rules No. 260n) approved the Good Pharmacy Practice rules and the storage rules, in effect from 1 September 2025. The requirements for internal audit, logs and documents in a pharmacy’s sales area under the previous rules, approved by Order of the Russian Ministry of Health No. 647n of 31 August 2016, differ from the requirements of Rules No. 259n (Table 2).
Table 2. Changes to licensing and to the rules to which Resolution No. 547 refers
| Item | Previously | Now |
|---|---|---|
| Time limit for deciding on a license application | 10 working days for applications of any type (version of Resolution No. 547 of 6 November 2024) | 10 working days for medicines for medical use, 8 working days for veterinary use (version of 27 March 2026, from 5 April 2026) |
| Education of an individual entrepreneur and an employee for veterinary use, change under Resolution No. 232 | Higher or secondary pharmaceutical education and a specialist certificate or accreditation, or higher or secondary veterinary education and a specialist certificate (version of Resolution No. 547 of 6 November 2024) | Veterinary education requires a specialist certificate or completed specialist accreditation in veterinary medicine (from 1 March 2026) |
| Education of an individual entrepreneur and an employee for veterinary use, change under Resolution No. 324 | Higher or secondary veterinary education and a specialist certificate or completed specialist accreditation in veterinary medicine (Resolution No. 547 as amended by Resolution No. 232) | Higher or secondary veterinary education; the certificate and accreditation for this education are removed (from 5 April 2026) |
| Good Pharmacy Practice rules | Order of the Russian Ministry of Health No. 647n of 31 August 2016 (in effect from 1 March 2017 to 31 August 2025) | Rules approved by Order of the Russian Ministry of Health No. 259n of 29 April 2025, in effect from 1 September 2025 to 1 September 2031 |
| Internal audit of a pharmacy | The manager analyzed operations under an approved schedule, and the Rules did not name the frequency of audit; audits were conducted by persons specially appointed by the manager | An audit is conducted under an annual plan at least once every six months; the person responsible for implementing and maintaining the quality system is responsible for organizing and conducting it and prepares the report |
| Pharmacy logs | 19 logs on the list (among them logs of briefings, registration of orders, records of inspections, records of shortages, registration of incoming inspection results); the temperature inside refrigeration equipment was recorded periodically; the manager could approve other types and forms of logs | 12 logs on the list, which begins with the words «include, among others»; the temperature inside refrigeration equipment is recorded daily; a log of completed orders and deliveries for distance trade is added; logs may be signed with a simple electronic signature |
| Documents in the sales area | A copy of the pharmaceutical activity license and, if there is one, a copy of the license for the circulation of narcotic drugs | An extract from the register of pharmaceutical activity licenses, an extract from the register of licenses for the circulation of narcotic drugs and an extract from the register of distance trade permits, if there are any |
| Rules for storing medicines for medical use | Order of the Russian Ministry of Health and Social Development No. 706n of 23 August 2010 and Order of the Russian Ministry of Health and Social Development No. 1221n of 28 December 2010 | Rules approved by Order of the Russian Ministry of Health No. 260n of 29 April 2025, in effect from 1 September 2025 to 1 September 2031 |
Resolution No. 232 took effect on 1 March 2026. The text of Resolution No. 324 has no effective date of its own, and the version of Resolution No. 547 of 27 March 2026 applies from 5 April 2026. Neither Resolution No. 232 nor Resolution No. 324 has transitional provisions on applications filed before the changes began to apply. The texts of these resolutions do not say how the 8-working-day time limit and the removal of the certificate and accreditation relate to such applications. For pharmaceutical education (medicines for medical use and the pharmaceutical branch of veterinary use), neither resolution changes the requirements.
The provisions of Resolution No. 547 on the interdepartmental request to the Federal Service for Supervision in Education and Science (Rosobrnadzor) mention a specialist certificate for veterinary education, although after Resolution No. 324 the requirements for veterinary education no longer contain it. Resolution No. 232 and Resolution No. 324 do not change these provisions.
For the premises and equipment of wholesale organizations, pharmacy organizations and individual entrepreneurs working with medicines for medical use, Resolution No. 547 refers to rules approved by the authorized federal executive body and does not give the details of the orders. A change of order therefore changes these requirements without a change in the text of Resolution No. 547.
Which licensing requirements are checked for an applicant and a licensee
Resolution No. 547 lists the requirements for a license applicant and for a licensee separately.
The premises and equipment must belong to the license applicant or the licensee by right of ownership or on another lawful basis that gives the right of possession and use, and must comply with 61-FZ and with the rules that depend on the type of work (Table 3). For wholesale trade, the Licensing Regulation also names the Good Distribution Practice (GDP) rules in effect in the Eurasian Economic Union (EAEU), approved by Decision of the Council of the Eurasian Economic Commission (EEC) No. 80 of 3 November 2016 (hereinafter the EAEU GDP Rules).
Table 3. Rules with which the premises and equipment of a license applicant must comply
| Type of work | Requirements of 61-FZ | Rules |
|---|---|---|
| Wholesale trade for medical use | For wholesale trade | EAEU GDP Rules; storage rules |
| Retail trade for medical use (pharmacy organization) | For retail trade | Good Pharmacy Practice rules; storage rules |
| Work of an individual entrepreneur for medical use | For retail trade | Good Pharmacy Practice rules; storage rules |
| Wholesale trade for veterinary use | For wholesale trade | EAEU GDP Rules; storage rules for veterinary use |
| Retail trade for veterinary use | For retail trade | Good Pharmacy Practice rules for veterinary use; storage rules for veterinary use |
| Veterinary pharmacy organization or individual entrepreneur that prepares veterinary medicinal products | For preparation and dispensing | Good Pharmacy Practice rules, preparation and dispensing rules, storage rules, all for veterinary use |
For a licensee, Resolution No. 547 names the same rules. A medical organization that applies for a license or already holds one must have a license for medical activity.
Requirements for the responsible person, employees and information in the Unified State Health Information System (EGISZ):
Work with medicines for medical use requires a person responsible for implementing and maintaining the quality system for the storage and transport of medicinal products and for keeping standard operating procedures (SOPs, documents that set out an employee’s actions) up to date.
Employees under employment contracts whose activity is connected with wholesale trade, storage, retail trade, dispensing and preparation of medicines for medical use must have higher or secondary pharmaceutical education and a specialist certificate or completed accreditation. Separate subdivisions of medical organizations require additional professional education in retail trade, where the right to medical activity exists.
Until 1 January 2026, persons with pharmaceutical education and a specialist certificate had the right to engage in pharmaceutical activity under Federal Law No. 323-FZ of 21 November 2011 «On the Fundamentals of Health Protection of Citizens in the Russian Federation» (hereinafter 323-FZ). The transition to specialist accreditation went in stages from 1 January 2016 to 31 December 2025 inclusive. According to the ConsultantPlus reference of 16 September 2026, from 1 January 2026 to 1 January 2027 persons with medical or pharmaceutical education may be admitted to pharmaceutical activity without accreditation. This applies to persons who conducted medical or pharmaceutical activity in 2025 in positions of medical or pharmaceutical workers and whose specialist certificate or accreditation expired between 1 January and 31 December 2025. The reference names as the basis Order of the Russian Ministry of Health No. 34n of 20 January 2026, which approves the cases and conditions of admission without accreditation.
Employees who prepare radiopharmaceutical medicinal products need higher or secondary pharmaceutical or medical education and additional professional education in radiochemistry and radiation safety.
An individual entrepreneur working with medicines for medical use must have higher or secondary pharmaceutical education and a specialist certificate or completed accreditation.
The requirements for an individual entrepreneur and employees working with medicines for veterinary use were changed by Resolution No. 232 and Resolution No. 324 (Table 2).
The licensee ensures continuing professional development of specialists with pharmaceutical or veterinary education at least once every 5 years.
The licensee enters in EGISZ information about the pharmaceutical organization, the individual entrepreneur and the employees who have concluded employment contracts with the licensee, in the procedure and within the time limits established by the Regulation on EGISZ approved by Resolution of the Government of the Russian Federation No. 140 of 9 February 2022 (hereinafter the EGISZ Regulation). Resolution No. 547 sets no time limits for entering the information. Resolution No. 547 does not impose this requirement on a license applicant.
In the EGISZ Regulation, the time limits for pharmaceutical organizations to enter information (employees, education, employment, general information about the organization, buildings and premises, structural subdivisions, equipment) are defined by reference to Resolution No. 547. Neither Resolution No. 547 nor the EGISZ Regulation gives a number of working days for pharmaceutical organizations. For medical organizations, 3 or 5 working days from receipt of updated data are given for the same cases.
In Letter of Roszdravnadzor No. 02i-362/26 of 22 April 2026 «On Mandatory Requirements for a Pharmacy Organization» (hereinafter Letter No. 02i-362/26), Roszdravnadzor states that a legal entity and an individual entrepreneur must enter information about the organization and pharmaceutical workers in EGISZ immediately after receiving a license. The letter does not give a number of days.
Information about pharmaceutical organizations and workers is entered in the federal register of medical and pharmaceutical workers and the federal register of medical and pharmaceutical organizations in the part that concerns activity in the sphere of circulation of medicines for medical use. Roszdravnadzor monitors compliance by the suppliers of information to the federal register of medical and pharmaceutical organizations with the requirements on the procedure, time limits, currency and reliability of the information.
A licensee must comply with the rules of work for each type of activity:
for wholesale trade in medicines for medical use: the requirements of 61-FZ for wholesale trade and for entering information on medicinal products in the system for monitoring the movement of medicinal products, the EAEU GDP Rules, the storage rules, the rules for registering transactions with medicines subject to item-by-item quantitative record-keeping, and the rules for keeping and storing special record logs;
for wholesale trade in medicines for veterinary use: the requirements of 61-FZ for wholesale trade and for storage of medicines, the storage rules for veterinary use and the EAEU GDP Rules;
for retail trade in medicinal products for medical use (pharmacy organization and individual entrepreneur): the Good Pharmacy Practice rules, the storage rules, the rules for dispensing medicinal products, the rules for dispensing narcotic drugs and psychotropic substances registered as medicinal products, the same rules for registering transactions and keeping logs, and the requirements of 61-FZ on ensuring a minimum range of medicinal products and on entering information in the system for monitoring the movement of medicinal products;
for a medical organization and its separate subdivision: the rules for dispensing medicinal products, in accordance with the requirement of 61-FZ to enter information on medicinal products in the system for monitoring the movement of medicinal products;
for retail trade in medicinal products for veterinary use (a veterinary pharmacy organization, a veterinary organization and an individual entrepreneur that hold a license): the Good Pharmacy Practice rules and the storage rules, both sets for veterinary use;
for preparation and dispensing of medicinal products: the preparation and dispensing rules for medical use, the procedure for preparing radiopharmaceutical medicinal products or the preparation and dispensing rules for veterinary use;
for storage of medicines: the storage rules for medicines for medical use or for veterinary use;
for all licensees: the requirements of 61-FZ on the prohibition of the sale of certain medicines.
How a wholesale organization passes storage to another licensee
A wholesale organization for medicines for medical use may have no premises of its own for storage. The premises and equipment may belong to another licensee that holds a license for wholesale trade, provided there is a contract (for 12 months or more) on outsourcing the work (services) of storage. Employees whose activity is connected with wholesale trade and storage must work under an employment contract with the license applicant. If the contract is terminated, the licensee must send Roszdravnadzor an application to amend the license register to remove the facility.
Under the EAEU GDP Rules, the quality system includes control and review of the activity that is outsourced.
Outsourced activity must take into account possible risks to quality and contain:
an assessment of the suitability and competence of the contractor and verification of its permitting documents;
a definition of responsibility, of the procedure for interaction of the parties and of the exchange of information on actions that relate to quality;
monitoring and review of the contractor’s activity, with regular introduction of improvement measures.
What Rules No. 259n and No. 260n provide
Pharmacy organizations and individual entrepreneurs that hold a license apply Rules No. 259n (the Good Pharmacy Practice Rules for Medicinal Products for Medical Use) and Rules No. 260n (the Rules for Storing Medicines for Medical Use). Rules No. 260n also apply to manufacturers, wholesale organizations, and medical and other organizations that hold a license for pharmaceutical or medical activity.
Quality system, premises and incoming inspection under Rules No. 259n
The quality system (a set of measures to ensure the quality of retail trade in medicinal products) includes a definition of the processes, their sequence and interaction, parameters for maintaining them, and provisions on measures to improve customer service. The documentation of the quality system is developed and endorsed by the person responsible for implementing and maintaining the quality system (the Responsible Person). The manager approves the documentation.
The documentation includes, among others:
a document on policy and objectives of activity;
a quality manual for retail trade;
SOPs for all processes that affect the quality, efficacy and safety of medicinal products;
documents with the results of internal audits;
logs and the organizational structure;
internal work rules (except for small businesses);
a schedule for the analysis of the quality system and a schedule for staff training;
a procedure for selecting and evaluating suppliers.
Logs are kept on paper or electronic media. Among them are a log of daily registration of temperature and humidity in storage premises and a log of daily registration of the temperature of refrigeration equipment. Two more logs are needed for medicines subject to item-by-item quantitative record-keeping (a log of transactions) and for medicines with a shelf life of less than 6 months (a log of shelf lives).
The manager conducts an internal audit, that is, an assessment of employees’ activity. The results of the audit are documented. The manager determines corrective and preventive measures. An internal audit is conducted independently by employees specially appointed by the manager or by persons engaged under a contract, and the Responsible Person is responsible for organizing and conducting the audit. The procedure for the audit is set out in an SOP, which defines the purpose, tasks and time limits, the grounds, the rights and duties of participants, the procedure for registering and analyzing the results and the procedure for using them. The audit follows an annual plan approved by the manager and takes place at least once every six months. Following the audit, the Responsible Person prepares a report with measures to remedy violations.
The premises of a pharmacy are located in a building (structure), are functionally combined and are separated from other organizations. Measuring instruments are subject to calibration and periodic verification. In incoming inspection, the appearance, color and odor, the integrity of the packaging, the compliance of the labeling, the completion of accompanying documents and the information on entry into civil circulation are checked; the manager appoints the responsible persons or an incoming inspection committee by order.
What Roszdravnadzor stated about pharmacy premises and equipment
Letter No. 02i-362/26 was prepared following an analysis of the reasons why applicants withdrew applications before the decision of the licensing authority and received a refusal of a license. Roszdravnadzor states the purpose of the letter: to give methodological assistance to license applicants and licensees and to reduce the number of refusals. The letter refers to Resolution No. 547, Rules No. 259n and Rules No. 260n. According to the letter, the legal entity or individual entrepreneur determines the quantity of equipment independently, based on the planned volume of circulation and storage.
For retail trade, the letter names a set of premises or areas that are functionally combined, separated from other organizations and exclude access by unauthorized persons:
a sales area;
the main stock of medicinal products;
preparation of medicinal products (where necessary);
receiving, with the possibility of cleaning containers;
storage of products that need special conditions;
separate storage of products for which Rules No. 260n provide for separate premises or areas (the list is given in the section on storage under Rules No. 260n);
quarantine storage with restricted access;
administrative and staff premises.
Rules No. 260n also provide for premises or areas for sampling and for dispatch for all entities in the circulation of medicines; the letter does not name them.
Roszdravnadzor attached to the letter a list called «List of Key Equipment for Ensuring the Proper Procedure for Organizing and Carrying Out the Circulation of Medicinal Products for Medical Use». It lists equipment for storage, transport, dispensing and retail trade:
equipment for protection from weather conditions, for example a heat curtain and a heat gun: Rules No. 260n provide for protection of loading and unloading from precipitation and from low and high temperatures;
air conditioning systems;
cold rooms and refrigerators;
a ventilation system;
an air humidification and dehumidification system: the letter refers to the requirements of Rules No. 259n for equipment that ensures the preservation of the quality of products; neither Rules No. 259n nor Rules No. 260n contain such a system by name;
equipment for loading and unloading;
shelving, cabinets, display cases, gondolas, pallets and platforms;
safes and lockable cabinets for medicines subject to item-by-item quantitative record-keeping;
thermohygrometers and other instruments for measuring temperature and humidity (Rules No. 259n provide for their calibration and verification);
backup equipment in case of failure of equipment from the list: the letter refers only to the requirements of Resolution No. 547 for premises and equipment; Rules No. 259n and Rules No. 260n do not name backup equipment;
hardware and software, including for integrated automation of trade: Rules No. 259n speak of information systems for the movement of goods and for detecting falsified, counterfeit and substandard products;
isothermal packaging, containers and transport that maintains the required temperature conditions.
Separate lists of equipment for preparing medicinal products and for preparing radiopharmaceutical medicinal products are contained in the materials attached to the letter.
The letter differs from the text of Rules No. 259n and No. 260n on the temperature conditions for temperature-sensitive products, on the equipment of the quarantine storage area and on the storage of prescription products. For temperature-sensitive products, according to the letter, cold rooms or refrigerators set to two ranges are needed, from +2 °C to +8 °C and from +8 °C to +15 °C. Rules No. 260n provide for the storage of temperature-sensitive medicines in cold rooms, cabinets or refrigerators; the ranges are not given in them. According to the letter, the quarantine storage area is also equipped with refrigeration equipment, because a product may return from it to civil circulation. According to the letter, prescription products are kept in closed cabinets or display cases, while Rules No. 260n allow such products, if they are not subject to item-by-item quantitative record-keeping, to be kept in display cases and in glass and open cabinets with the mark «by prescription for a medicinal product», provided that customers do not have access to them.
Storage at wholesale organizations under Rules No. 260n
The manager approves SOPs that regulate the actions of employees during storage, the servicing and verification of measuring instruments and equipment, the keeping of records and reports, and receiving and placement, and organizes control of compliance with them. The quality system must guarantee that the responsibility of employees is defined and that every violation leads to an internal audit and to corrective actions with time limits and responsible persons. The manager appoints a responsible person who monitors the effectiveness of the quality system, including by conducting scheduled internal audits, and who updates the SOPs depending on the risk category of the facility of federal state control (supervision).
Rules No. 260n do not state the frequency of scheduled internal audits. The EAEU GDP Rules provide for a self-inspection program that covers, over a defined period, all aspects of Good Distribution Practice, the requirements of the legislation of the member states, guidelines and procedures.
The area of storage premises of a wholesale organization, other than administrative and staff premises, is determined by the volume of medicines stored and is at least 150 square meters. The premises and equipment are organized under the requirements of the EAEU GDP Rules for premises and equipment and are combined into a single block that is separated from premises not intended for storage and excludes the crossing of technological flows.
The area of storage premises of any entity is divided into premises or areas for the following functions:
receiving, with a dedicated area for cleaning containers;
main storage;
storage of medicines that need special conditions;
separate storage of falsified, substandard and counterfeit medicines, and also of medicinal products without information on the application of means of identification or on entry into civil circulation, with the information blocked in the system for monitoring the movement of medicinal products, with suspended use, with terminated civil circulation, with an expired shelf life, and of products for which the requirements established by 61-FZ are not met;
quarantine storage;
sampling;
dispatch (shipment).
Medicinal products with terminated civil circulation and quarantined products are stored separately, with restricted access, in a closed room or a lockable cabinet. Instead of physical separation, the organization of areas through a computerized system is allowed, with the required level of security and validation.
Medicines are stored at a temperature from +15 °C to +25 °C and a relative humidity of no more than 65%, unless the manufacturer has stated other conditions. An employee authorized by the manager checks the conditions daily, including weekends and public holidays, and records the result in a log on paper or in electronic form with archiving; monitoring is carried out with verified measuring instruments or an automated round-the-clock monitoring system. At a wholesale organization, measuring instruments are placed based on the results of temperature mapping (a study of the distribution of temperature in storage premises). Mapping is repeated based on the results of risk analysis and when the construction of the premises or equipment changes. Medicines must not be placed on the floor without a pallet. Pallets in several tiers in height are allowed only on racks. At receiving, conformity with the shipping documents is checked by range, quantity and quality, as are the storage conditions during transport, damage to the transport containers and the information in the system for monitoring the movement of medicinal products.
How to obtain a license and amend the register
An application for a license is filed as an electronic document through the federal state information system «Unified Portal of State and Municipal Services (Functions)» (hereinafter the Unified Portal). The legal entity or individual entrepreneur signs the application with an electronic signature. The application states the information that 99-FZ requires. The applicant may withdraw the application before the decision of the licensing authority.
The licensing authority requests information from state bodies:
the Federal Tax Service:
taxpayer identification number and primary state registration number;
the Pension and Social Insurance Fund of the Russian Federation: employment contracts of employees;
the Federal Service for State Registration, Cadastre and Cartography: rights to premises;
Rosobrnadzor: education of employees;
the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing: the sanitary and epidemiological conclusion.
If the information cannot be obtained, the applicant may submit the documents on its own initiative.
The licensing authority decides to grant a license or to refuse no later than 10 working days from the filing of the application for medicines for medical use and no later than 8 working days for veterinary use. For activity in the territory of a closed administrative-territorial entity, the time limit is no more than 20 working days from acceptance of the application. Under 99-FZ, the general time limit is 45 working days. 99-FZ allows the licensing regulation to shorten this time limit.
The assessment of compliance is carried out in the form of an on-site assessment. If an applicant declares retail trade in medicinal products or a licensee declares a new address of retail trade, the use of remote interaction tools, including video communication, is provided for. The applicant states in the application that it has the technical ability to use such tools with identification through the unified system of identification and authentication. An official of the licensing authority decides on the remote format. The assessment is carried out under an assessment sheet with a list of verification questions, the form of which is approved by the licensing authority. In Letter No. 02i-362/26, Roszdravnadzor states that the assessment of retail trade is carried out with remote interaction tools, including video communication through the mobile application «Inspector». The licensing authority may engage experts or expert organizations that have no interest in the result, free of charge for the applicant. If the assessment reveals non-compliance, the assessment report states which licensing requirements the applicant does not meet and by which regulatory legal act (with indication of its structural unit) the requirement is established.
99-FZ gives the following grounds for refusing a license:
inaccurate or distorted information in the application and the attached documents;
non-compliance of the applicant with licensing requirements, established during the assessment;
the applicant’s holding of a valid license for this type of activity granted by the same licensing authority, unless the licensing regulation provides otherwise.
The licensing authority sends the applicant a notice of refusal with the reasons and with reference to the provisions of regulatory legal acts within three working days of the decision. If the assessment reveals non-compliance only for individual work or services, the license is granted at the applicant’s request for the work and services for which compliance is confirmed. The request is stated in the application or filed before the decision is made.
A license is considered granted from the moment the entry is made in the license register. The licensing authority makes the entry on the day of the decision and sends the licensee a notice within one working day after the entry.
The state fee for granting a license under the Tax Code of the Russian Federation (Part Two, hereinafter the Tax Code) is RUB 7,500. Applications filed from 1 January 2024 to 31 December 2029 are exempt from the fee for granting a license, for amending the license register and for extending the validity of a license (Resolution of the Government of the Russian Federation No. 353 of 12 March 2022 «On Special Provisions for Permitting Activities in the Russian Federation», hereinafter Resolution No. 353). The exemption does not apply to certain types of activity that Resolution No. 353 excludes by reference to the list in 99-FZ; pharmaceutical activity is not among them. An extract from the license register in the form of an electronic document signed with the qualified electronic signature of the licensing authority is provided free of charge. Licensing authorities are prohibited from charging any other fee for licensing.
For a new address, the licensee files an application to amend the license register with the new address. For new work or services, the licensee states them in the same application. The licensing authority decides no later than 5 working days from receipt of the application; for a closed administrative-territorial entity, the time limit does not exceed 20 working days. The application may be withdrawn before the decision. The state fee under the Tax Code for additions to the information on addresses, work and services is RUB 3,500, and in other cases RUB 750. If there are several grounds, the highest fee is paid. For applications filed from 1 January 2024 to 31 December 2029, this fee is not paid under Resolution No. 353.
How a licensee is inspected and what liability is provided
Compliance with licensing requirements is assessed in federal state control (supervision) in the sphere of circulation of medicines. For organizations and individual entrepreneurs that are licensed by regional authorities, Roszdravnadzor carries out this assessment, except for licensees that have filed applications to amend the license register. Checking compliance with the licensing requirements for pharmaceutical activity is carried out as a separate type of state control (supervision) under Federal Law No. 248-FZ of 31 July 2020 «On State Control (Supervision) and Municipal Control in the Russian Federation».
A gross violation under Resolution No. 547 is a licensee’s failure to meet one of the requirements for a licensee that entailed the consequences established by 99-FZ.
Under 99-FZ, violations that entailed the following may be gross:
the emergence of a threat of harm to the life and health of citizens, to animals, plants, the environment and cultural heritage sites of the peoples of the Russian Federation, and also a threat of man-made emergencies;
human casualties or serious harm to the health of citizens, moderately serious harm to the health of two or more citizens, harm to animals, plants, the environment and cultural heritage sites, man-made emergencies, damage to the rights and legitimate interests of citizens, to the defense of the country and to state security.
The Code of the Russian Federation on Administrative Offenses (hereinafter the Administrative Offenses Code) instructs the Russian Government to establish the concept of a gross violation for each licensed type of activity. The amounts of penalties for violations of licensing requirements and trade rules are set in the Administrative Offenses Code (Table 4).
Table 4. Liability under the Administrative Offenses Code for violations of licensing requirements and trade rules
| Violation | Administrative penalty |
|---|---|
| Business activity without a license, if it is mandatory | Citizens from RUB 2,000 to 2,500; officials from RUB 4,000 to 5,000; legal entities from RUB 40,000 to 50,000; with or without confiscation of manufactured products, instruments of production and raw materials |
| Violation of license requirements and conditions, other than dispensing without a prescription of products subject to item-by-item quantitative record-keeping (the last row of the table) | A warning or fine: citizens from RUB 1,500 to 2,000; officials from RUB 3,000 to 4,000; legal entities from RUB 30,000 to 40,000 |
| Gross violation of license requirements and conditions, other than dispensing without a prescription of products subject to item-by-item quantitative record-keeping (the last row of the table) | Persons acting without forming a legal entity from RUB 4,000 to 8,000 or suspension of activity for up to 90 days; officials from RUB 5,000 to 10,000; legal entities from RUB 100,000 to 200,000 or suspension of activity for up to 90 days |
| Violation of the rules of wholesale trade in medicines and of the procedure for retail trade in medicinal products (except the cases that the Administrative Offenses Code relates to the circulation of falsified, counterfeit, substandard and unregistered medicines and medical devices and to the circulation of falsified dietary supplements, to dispensing without a prescription of products subject to item-by-item quantitative record-keeping, and to the violation of the maximum wholesale and retail markups to the actual selling prices of manufacturers) | Citizens from RUB 1,500 to 3,000; officials from RUB 5,000 to 10,000; legal entities from RUB 20,000 to 30,000 |
| Violation of the rules for dispensing medicinal products subject to item-by-item quantitative record-keeping, consisting in dispensing without a prescription, if there are no signs of a criminally punishable act | Officials from RUB 10,000 to 20,000 or disqualification for a period from 6 months to 1 year; persons acting without forming a legal entity from RUB 50,000 to 100,000; legal entities from RUB 150,000 to 200,000 |
Pharmaceutical workers who commit a violation for which the Administrative Offenses Code provides the penalty from the last row of Table 4 bear liability as officials. The articles of the Administrative Offenses Code on liability for violation of licensing requirements and trade rules contain no rule on choosing between these types of liability when a violation of a licensing requirement coincides with a violation of trade rules.
A case concerning a pharmacy organization is examined in the Review of Judicial Practice «On Certain Issues Arising in the Consideration by Commercial Courts of Cases on Administrative Offenses Provided for by Chapter 14 of the Code of the Russian Federation on Administrative Offenses», approved by the Presidium of the Supreme Court of the Russian Federation on 6 December 2017. The prosecutor identified the storage and sale of medicinal products in violation of the storage rules and the absence of a minimum range. The court of first instance stated that the company’s actions are qualified under the provision of the Administrative Offenses Code on violation of the rules of trade in medicinal products, and terminated the proceedings. The court of appeal overturned this decision: a violation of licensing requirements that is gross in nature is subject to qualification under the provision of the Administrative Offenses Code on gross violation of licensing requirements, regardless of the type of licensed activity. This position is based on the Licensing Regulation approved by Resolution of the Government of the Russian Federation No. 1081 of 22 December 2011 «On the Licensing of Pharmaceutical Activities»; Resolution No. 547 repealed that resolution. The position does not speak to the penalty for a violation of licensing requirements that is not gross.
The licensing authority suspends a license in the cases listed in 99-FZ, including when the licensee is brought to administrative liability for failure to comply in time with an order to remedy a gross violation and when an administrative suspension of activity is imposed for a gross violation. Suspension is possible for all work and services, for individual work and services, or for individual places where the licensee carries out its activity. A license is cancelled by a court on the application of the licensing authority.
What to do
Determine the authority and the types of work. Select the work from the list in the Licensing Regulation: nine items for medicines for medical use and eight for veterinary use (Table 1). The authority is determined under Resolution No. 547: Roszdravnadzor licenses wholesale organizations for medicines for medical use and pharmacy organizations subordinate to federal executive authorities; for other organizations, individual entrepreneurs and foreign legal entities the license is issued by the executive authority of a constituent entity of the Russian Federation; veterinary use is licensed by Rosselkhoznadzor.
Prepare the premises and equipment under Rules No. 259n and No. 260n. Confirm the right of possession and use of the premises. For a wholesale warehouse, check a storage area of at least 150 square meters without administrative and staff premises, the storage areas under Rules No. 260n and the verification of measuring instruments. If there is no warehouse, conclude a contract (for 12 months or more) with a licensee that holds a license for wholesale trade, and assess that licensee against the requirements of the EAEU GDP Rules for outsourcing. For a pharmacy, check the premises and equipment against the list in Letter No. 02i-362/26 and against the requirements of Rules No. 259n and No. 260n to which the list refers.
Appoint a responsible person, approve SOPs and a plan of internal audits. For a pharmacy, set out the audit procedure in an SOP and approve an annual plan of internal audits with a period of at least once every six months. For a wholesale organization, approve SOPs, appoint a responsible person and introduce a self-inspection program under the EAEU GDP Rules with a period that the organization sets itself.
File the application through the Unified Portal. Sign the application with an electronic signature. No state fee is paid under Resolution No. 353 for an application filed up to and including 31 December 2029. For an application filed later, the fee under the current Tax Code is RUB 7,500. For retail trade, state in the application the technical ability to use remote interaction tools, including video communication, during the on-site assessment, with identification through the unified system of identification and authentication. If there is a risk of non-compliance for part of the work, include in the application a request for a license for the work for which compliance will be confirmed.
Enter information in EGISZ and set dates for continuing professional development. Enter data on the organization, on buildings and premises, on equipment and on employees under the procedure of the EGISZ Regulation. The acts give no number of working days for pharmaceutical organizations. In Letter No. 02i-362/26, Roszdravnadzor writes of entering the information immediately after receiving a license, so set your own time limit for entering it in an SOP. Mark in the calendar the continuing professional development of each specialist at least once every 5 years.
Legal framework:
1. Federal Law No. 99-FZ of 4 May 2011 «On the Licensing of Certain Types of Activity» (as amended on 4 August 2026)
2. Resolution of the Government of the Russian Federation No. 547 of 31 March 2022 «On Approval of the Regulation on the Licensing of Pharmaceutical Activities» (as amended on 27 March 2026)
3. Resolution of the Government of the Russian Federation No. 232 of 26 February 2025 «On Amendments to Resolution of the Government of the Russian Federation No. 547 of 31 March 2022» (in effect from 1 March 2026)
4. Resolution of the Government of the Russian Federation No. 324 of 27 March 2026 «On Amendments to Resolution of the Government of the Russian Federation No. 547 of 31 March 2022»
5. Order of the Russian Ministry of Health No. 259n of 29 April 2025 «On Approval of the Good Pharmacy Practice Rules for Medicinal Products for Medical Use» (registered by the Russian Ministry of Justice on 30 May 2025, No. 82462)
6. Order of the Russian Ministry of Health No. 260n of 29 April 2025 «On Approval of the Rules for Storing Medicines for Medical Use» (registered by the Russian Ministry of Justice on 2 June 2025, No. 82490)
7. Decision of the EEC Council No. 80 of 3 November 2016 «On Approval of the Good Distribution Practice Rules within the Eurasian Economic Union»
8. Federal Law No. 61-FZ of 12 April 2010 «On the Circulation of Medicines» (as amended on 4 August 2026; the rules of the pilot project with mobile pharmacy units were introduced by Federal Law No. 125-FZ of 2 May 2026)
9. Federal Law No. 323-FZ of 21 November 2011 «On the Fundamentals of Health Protection of Citizens in the Russian Federation» (as amended on 4 August 2026)
10. Federal Law No. 248-FZ of 31 July 2020 «On State Control (Supervision) and Municipal Control in the Russian Federation» (as amended on 4 August 2026)
11. Resolution of the Government of the Russian Federation No. 140 of 9 February 2022 «On the Unified State Health Information System» (version with amendments up to Resolution of the Government of the Russian Federation No. 211 of 2 March 2026, which took effect on 1 September 2026)
12. Resolution of the Government of the Russian Federation No. 353 of 12 March 2022 «On Special Provisions for Permitting Activities in the Russian Federation» (as amended on 23 September 2026)
13. Tax Code of the Russian Federation (Part Two) No. 117-FZ of 5 August 2000 (as amended on 4 August 2026)
14. Code of the Russian Federation on Administrative Offenses No. 195-FZ of 30 December 2001 (as amended on 4 August 2026)
15. Order of the Russian Ministry of Health No. 34n of 20 January 2026 (approves the Cases and Conditions under Which Individuals May Be Admitted to Medical and/or Pharmaceutical Activity without Completing Specialist Accreditation and/or in Specialties Not Provided for by a Specialist Certificate or Specialist Accreditation; the title of the order is being clarified)
16. Letter of the Federal Service for Surveillance in Healthcare No. 02i-362/26 of 22 April 2026 «On Mandatory Requirements for a Pharmacy Organization» (with the attachment «List of Key Equipment for Ensuring the Proper Procedure for Organizing and Carrying Out the Circulation of Medicinal Products for Medical Use»)
17. Review of Judicial Practice «On Certain Issues Arising in the Consideration by Commercial Courts of Cases on Administrative Offenses Provided for by Chapter 14 of the Code of the Russian Federation on Administrative Offenses», approved by the Presidium of the Supreme Court of the Russian Federation on 6 December 2017: position 6
Repealed acts mentioned in the text (Orders of the Russian Ministry of Health No. 259n and No. 260n repealed Order No. 647n and Orders No. 706n and No. 1221n):
18. Order of the Russian Ministry of Health No. 647n of 31 August 2016 «On Approval of the Good Pharmacy Practice Rules for Medicinal Products for Medical Use» (registered by the Russian Ministry of Justice on 9 January 2017, No. 45113; in effect from 1 March 2017 to 31 August 2025)
19. Order of the Russian Ministry of Health and Social Development No. 706n of 23 August 2010 «On Approval of the Rules for Storing Medicines» (registered by the Russian Ministry of Justice on 4 October 2010, No. 18608)
20. Order of the Russian Ministry of Health and Social Development No. 1221n of 28 December 2010 «On Amendments to the Rules for Storing Medicines Approved by Order of the Ministry of Health and Social Development of the Russian Federation No. 706n of 23 August 2010» (registered by the Russian Ministry of Justice on 4 February 2011, No. 19703)
21. Resolution of the Government of the Russian Federation No. 1081 of 22 December 2011 «On the Licensing of Pharmaceutical Activities» (repealed by Resolution No. 547)